Comparison of Current Regulatory Status for Gene-Based Vaccines in the U.S., Europe and Japan
Gene-based vaccines as typified by plasmid DNA vaccines and recombinant viral-vectored vaccines are expected as promising solutions against infectious diseases for which no effective prophylactic vaccines exist such as HIV, dengue virus, Ebola virus and malaria, and for which more improved vaccines...
Main Authors: | Yoshikazu Nakayama, Atsushi Aruga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/3/1/186 |
Similar Items
-
Vaccines against Botulism
by: Grace Sundeen, et al.
Published: (2017-09-01) -
A Sneak Peek into COVID-19 Vaccines-Present Status
by: SWATHI GURAJALA
Published: (2021-03-01) -
Application of bacterial shuttle vectors in designing new vaccines against infectious diseases: brief report
by: Kobra Salimiyan Rizi, et al.
Published: (2018-12-01) -
A COMPREHENSIVE REVIEW OF A RACE OF VACCINATION AGAINST COVID - 19 VIRUS: THE RECENT VACCINES DEVELOPED
by: Maimonah Qasim Yahya, et al.
Published: (2021-09-01) -
Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants
by: Abdellatif Bouazzaoui, et al.
Published: (2021-01-01)